title: Two compound heterozygous novel SLC39A4 mutations in generalized eczematoid acrodermatitis enteropathica.
authors.forename: Cheng-Rang
authors.initials: CR
authors.lastname: Li
authors.forename: Su-Ying
authors.initials: SY
authors.lastname: Feng
authors.forename: Qiang
authors.initials: Q
authors.lastname: Wang
authors.forename: Xiu-Lian
authors.initials: XL
authors.lastname: Xu
authors.forename: Yu-Wei
authors.initials: YW
authors.lastname: Pan
authors.forename: Yan
authors.initials: Y
authors.lastname: Wang
authors.forename: Qi
authors.initials: Q
authors.lastname: Li
authors.forename: Baoxi
authors.initials: B
authors.lastname: Wang
mesh_terms: D000169:Acrodermatitis / Q000188:drug therapy / Q000235:genetics*; D001483:Base Sequence / Q000235:genetics*; D027682:Cation Transport Proteins / Q000235:genetics*; D002648:Child; D004252:DNA Mutational Analysis; D019587:Dietary Supplements; D006579:Heterozygote; D006801:Humans; D008297:Male; D020125:Mutation, Missense; D017384:Sequence Deletion; D015032:Zinc / Q000172:deficiency; D019287:Zinc Sulfate / Q000627:therapeutic use
chemical_list: D027682:Cation Transport Proteins; C486791:SLC39A4 protein, human; D019287:Zinc Sulfate; D015032:Zinc